doi:10.1016/j.diabet.2016.09.005 Rena G, Pearson ER, Sakamoto K
7 The trials long-term follow-up periods revealed sustained weight loss with semaglutide treatment, suggesting its potential to maintain reduced body weight over time
Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses
Compared with those who didn't take GLP-1s, those who did had a reduction of 10% to 20% in heart failure, cardiac arrest, lung failure, and pneumonia, and Alzheimer's disease and other types of dementia
) leads with the highest observed 32% buyer repeat rate
Patients whose only complaint is weight and who have no secondary concerns about skin, hair, inflammation, or tissue quality are better served by optimizing their GLP-1 protocol, adding resistance training, and addressing nutrition rather than adding a peptide that doesnt directly address their primary goal